- Discovery and Development of Trifluridine/Tipiracil (Lonsurf ™)
Norihiko Suzuki et al, 2018, Successful Drug Discovery CrossRef - Trifluridine/tipiracil: an emerging strategy for the management of gastrointestinal cancers
Marc Peeters et al, 2018, Future Oncology CrossRef - Further Therapeutic Options in Heavily Pretreated Colorectal Cancer Patients
Aneta L. Zygulska, 2019, Multidisciplinary Approach for Colorectal Cancer CrossRef - Trifluridine / tipiracil (FTd / TPI, TAS-102) in the treatment of patients with metastatic colon cancer: from preclinical experiments to routine clinical practice
M. Yu. Fedyanin, 2020, Pelvic Surgery and Oncology CrossRef - Trifluridine/tipiracil plus bevacizumab for third-line management of metastatic colorectal cancer: SUNLIGHT study design
Josep Tabernero et al, 2021, Future Oncology CrossRef - Quantitative Analysis of the Concentration of Trifluridine in Tumor Hypoxic Regions Using a Novel Platform Combining Functional Endoscopy and Mass Spectrometry
Shigehiro Koganemaru et al, 2024, Clinical Pharmacology & Therapeutics CrossRef - Recent advance in the development of novel, selective and potent FGFR inhibitors
Feng-Tao Liu et al, 2020, European Journal of Medicinal Chemistry CrossRef - Pyrimidine-based anticancer drugs
Galal H. Elgemeie et al, 2022, New Strategies Targeting Cancer Metabolism CrossRef - Lost in translation: Revisiting the use of tyrosine kinase inhibitors in colorectal cancer
Kirti K. Iyer et al, 2022, Cancer Treatment Reviews CrossRef - Extrapolating heterogeneous time-series gene expression data using Sagittarius
Addie Woicik et al, 2023, Nature Machine Intelligence CrossRef